Pamiparib
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Pamiparib, covering 2022-04-14 to 2026-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies [Phase 3]